OXBOF (Oxford BioDynamics) Institutional Ownership : 17.69% (As of Mar. 27, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Oxford BioDynamics's institutional ownership is 17.69%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Oxford BioDynamics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Oxford BioDynamics's Float Percentage Of Total Shares Outstanding is 0.00%.

Oxford BioDynamics Institutional Ownership Historical Data

The historical data trend for Oxford BioDynamics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Institutional Ownership Chart

Oxford BioDynamics Historical Data

The historical data trend for Oxford BioDynamics can be seen below:

	2024-05-31	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30	2024-12-31	2025-01-31	2025-02-28
Institutional Ownership	18.96	18.96	18.60	17.34	17.34	16.22	16.10	15.70	63.01	12.17

Oxford BioDynamics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Oxford BioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

OBD:UK LMQ:Germany

Address

John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.